ZGK-83923-20607 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2022-06-24
Dose 1 — Pfizer-BioNTech
2022-06-25
Registered in v-safe
2022-06-25
Health check-in — days 1–6 daily, dose 1, dependent
Feeling: Good · Site: Pain, Redness, Itching · None

Adult check-in
2022-06-26
Health check-in — days 1–6 daily, dose 1, dependent
Feeling: Good · Fatigue or tiredness

Adult check-in
2022-06-27
Health check-in — days 1–6 daily, dose 1, dependent
Feeling: Good · Site: Redness · None

Adult check-in
2022-06-28
Survey response — days 1–6 daily, dose 1, dependent
MedDRA: Rash — Feeling: Good · Rash, not including the immediate area around the injection site

Free text: 99% sure rash is unrelated to vaccine

MedDRA releases: 2024-11 · check-in free text available
2022-06-29
Health check-in — days 1–6 daily, dose 1, dependent
Feeling: Good · None

Adult check-in
2022-06-30
Health check-in — days 1–6 daily, dose 1, dependent
Feeling: Good · None

Adult check-in
2022-07-01
Health check-in — day 7, dose 1, dependent
Feeling: Good · None

Adult check-in
2022-07-08
Health check-in — day 14, dose 1, dependent
Feeling: Good

Adult check-in
2022-07-15
Dose 2 — Pfizer-BioNTech
2022-07-22
Health check-in — day 7, dose 2, dependent
Feeling: Good · None

Adult check-in
2022-07-29
Health check-in — day 14, dose 2, dependent
Feeling: Good

Adult check-in
2022-08-05
Health check-in — day 21, dose 2, dependent
Feeling: Good

Adult check-in
2022-08-12
Health check-in — day 28, dose 2, dependent
Feeling: Fair

Adult check-in
2022-08-19
Survey response — day 35, dose 2, dependent
MedDRA: Nasopharyngitis — Feeling: Good · Be unable to work or attend school

Free text: Common cold

MedDRA releases: 2024-11 · check-in free text available
2022-08-28
Health check-in — day 42, dose 2, dependent
Feeling: Good

Adult check-in
2022-10-14
Health check-in — 3 months, dose 2, dependent
Feeling: Good

Adult check-in
2023-01-13
Survey response — 6 months, dose 2, dependent
MedDRA: COVID-19, Nasopharyngitis — Feeling: Fair · Be unable to work or attend school

MedDRA releases: 2024-11

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2022-06-24	Pfizer-BioNTech	No
2	2022-07-15	Pfizer-BioNTech	No

Free text

Release 12 — days 1–6 daily, dose 1, dependent

2022-06-28

Systemic reaction (other): 99% sure rash is unrelated to vaccine

Release 12 — day 35, dose 2, dependent

2022-08-19

Symptoms: Common cold

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	COVID-19	·	·	✓
SD	Nasopharyngitis	·	·	✓
SRO	Rash	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release